Key F Inancial Inc Amgen Inc Transaction History

Key F Inancial Inc

$446 Million
Q3 2024

A detailed history of Key F Inancial Inc transactions in Amgen Inc stock. As of the latest transaction made, Key F Inancial Inc holds 1,301 shares of AMGN stock, worth $364,371. This represents 0.09% of its overall portfolio holdings.

Number of Shares

1,301

Previous 1,290 0.85%

Holding current value

$364,371

Previous $403,000 3.97%

% of portfolio

0.09%

Previous 0.1%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 29, 2024	BUY	$309.38 - $337.38 $3,403 - $3,711	11 Added 0.85%	1,301 $419,000
Q4 2023 Jan 31, 2024	SELL	$255.7 - $288.46 $511 - $576	-2 Reduced 0.15%	1,290 $371,000
Q2 2023 Jul 28, 2023	BUY	$214.27 - $253.37 $17,570 - $20,776	82 Added 6.78%	1,292 $286,000
Q1 2023 May 02, 2023	SELL	$225.79 - $275.2 $50,351 - $61,369	-223 Reduced 15.56%	1,210 $292,000
Q3 2022 Oct 28, 2022	SELL	$224.46 - $253.15 $72,725 - $82,020	-324 Reduced 18.44%	1,433 $323,000
Q2 2022 Jul 26, 2022	BUY	$230.71 - $256.74 $2,768 - $3,080	12 Added 0.69%	1,757 $431,000
Q2 2021 Aug 02, 2021	BUY	$233.58 - $259.14 $72,643 - $80,592	311 Added 21.69%	1,745 $421,000
Q1 2021 Apr 30, 2021	BUY	$221.91 - $258.6 $2,441 - $2,844	11 Added 0.77%	1,434 $357,000
Q4 2020 Jan 29, 2021	BUY	$216.38 - $257.67 $11,035 - $13,141	51 Added 3.72%	1,423 $327,000
Q2 2020 Aug 07, 2020	BUY	$197.81 - $242.74 $3,956 - $4,854	20 Added 1.48%	1,372 $318,000
Q1 2020 May 05, 2020	SELL	$182.24 - $241.7 $54,672 - $72,510	-300 Reduced 18.16%	1,352 $282,000
Q4 2019 Feb 11, 2020	BUY	$189.21 - $243.2 $312,574 - $401,766	1,652 New	1,652 $398,000

Others Institutions Holding AMGN

# of Institutions

3,123

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $150B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Key F Inancial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Key F Inancial Inc with notifications on news.

Account

Key F Inancial Inc Amgen Inc Transaction History